GSK has revealed it will shut its main research and development hub in Stevenage and open a new flagship site in Cambridge with aims to slash costs by £1.9 billion to fund investment plans.
Around 1,800 staff work at the R&D site in Stevenage, Hertfordshire, but GSK has said the new 300,000sq ft centre in Cambridge will house more than 1,000 scientists, with a phased move for staff by 2029.